Key facts
- This page summarizes Richard S. Levy's Form 4 filing for Kiniksa Pharmaceuticals International, plc (KNSA).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 04 Aug 2026, 16:40.
Richard S. Levy - 01 Aug 2026 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)
- Reporting relationship
- Director
- Issuer ticker
- KNSA
- Reported as of
- 01 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Aug 2026, 16:40:33 UTC
- Prior SEC filing
- 02 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Douglas Barry, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Richard S. Levy filed Form 4 for Kiniksa Pharmaceuticals International, plc (KNSA) on 04 Aug 2026.
Change
- Previous filing in this sequence was filed on 02 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001454983
Primary reporting owner
Levy Richard S
- Relationship
- Director
- Address
- C/O KINIKSA PHARMACEUTICALS INT'L, 105 PICCADILLY, SECOND FLOOR, LONDON, UNITED KINGDOM
- Signature
- /s/ Douglas Barry, Attorney-in-Fact
- Signature date
- 04 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KNSA
transaction
Class A Ordinary Share
Options Exercise
- Transaction value
- Shares
- +403
- Change %
- +1.8%
- Price
- Shares after
- 22,359
- Date
- 01 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KNSA
transaction
Derivative
Restricted Share Units
Award
- Transaction value
- Shares
- +403
- Change %
- Price
- $0.000000*
- Shares after
- 403
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Class A Ordinary Shares
- Underlying amount
- 403
- Exercise price
- Footnotes
- F1, F2
KNSA
transaction
Derivative
Restricted Share Units
Options Exercise
- Transaction value
- Shares
- -403
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Class A Ordinary Shares
- Underlying amount
- 403
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
Footnote F2
The RSUs vested immediately upon grant on August 1, 2026; there was no expiration date for the RSUs.